Associations of PGK1 promoter hypomethylation and PGK1‐mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan‐cancer analysis

Fei Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Guo(The University of Texas MD Anderson Cancer Center), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Susheng Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhimin Lu(Zhejiang Chinese Medical University), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoli Feng(Chinese Academy of Sciences)
Cancer Communications
October 2, 2019
Cited by 50


Related Papers

Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Lipid metabolism and cancer
|The Journal of Experimental Medicine|2020|981